Women's and Children's Health Research Institute, Molecular Immunology Laboratory, Women's and Children's Hospital, 72 King William Road, North Adelaide, SA 5006, Australia.
Oncogene. 2012 Feb 23;31(8):1045-54. doi: 10.1038/onc.2011.293. Epub 2011 Jul 11.
The transcription factor FOXP3 has been identified as a tumour suppressor in the breast and prostate epithelia, but little is known about its specific mechanism of action. We have identified a feed-forward regulatory loop in which FOXP3 suppresses the expression of the oncogene SATB1. In particular, we demonstrate that SATB1 is not only a direct target of FOXP3 repression, but that FOXP3 also induces two miRs, miR-7 and miR-155, which specifically target the 3'-UTR of SATB1 to further regulate its expression. We conclude that FOXP3-regulated miRs form part of the mechanism by which FOXP3 prevents the transformation of the healthy breast epithelium to a cancerous phenotype. Approaches aimed at restoring FOXP3 function and the miRs it regulates could help provide new approaches to target breast cancer.
转录因子 FOXP3 已被鉴定为乳腺和前列腺上皮中的肿瘤抑制因子,但关于其具体作用机制知之甚少。我们已经确定了一个前馈调节回路,其中 FOXP3 抑制癌基因 SATB1 的表达。具体来说,我们证明 SATB1 不仅是 FOXP3 抑制的直接靶标,而且 FOXP3 还诱导两个 miR,miR-7 和 miR-155,它们特异性靶向 SATB1 的 3'-UTR,以进一步调节其表达。我们得出结论,FOXP3 调节的 miR 是 FOXP3 防止健康乳腺上皮向癌变表型转化的机制的一部分。旨在恢复 FOXP3 功能及其调节的 miR 的方法可能有助于提供针对乳腺癌的新方法。